title: Importance of uncharged polar residues and proline in the proximal two-thirds (Pro107-Ser128) of the highly conserved region of mouse ileal Na+-dependent bile acid transporter, Slc10a2, in transport activity and cellular expression.
abstract: BACKGROUND
  SLC10A2-mediated reabsorption of bile acids at the distal end of the ileum is the first step in enterohepatic circulation. Because bile acids act not only as detergents but also as signaling molecules in lipid metabolism and energy production, SLC10A2 is important as the key transporter for understanding the in vivo kinetics of bile acids. SLC10A family members and the homologous genes of various species share a highly conserved region corresponding to Gly104-Pro142 of SLC10A2. The functional importance of this region has not been fully elucidated.
  
  
  RESULTS
  To elucidate the functional importance of this region, we previously performed mutational analysis of the uncharged polar residues and proline in the distal one-third (Thr130-Pro142) of the highly conserved region in mouse Slc10a2. In this study, proline and uncharged polar residues in the remaining two-thirds of this region in mouse Slc10a2 were subjected to mutational analysis, and taurocholic acid uptake and cell surface localization were examined. Cell surface localization of Slc10a2 is necessary for bile acid absorption. Mutants in which Asp or Leu were substituted for Pro107 (P107N or P107L) were abundantly expressed, but their cell surface localization was impaired. The S126A mutant was completely impaired in cellular expression. The T110A and S128A mutants exhibited remarkably enhanced membrane expression. The S112A mutant was properly expressed at the cell surface but transport activity was completely lost. Replacement of Tyr117 with various amino acids resulted in reduced transport activity. The degree of reduction roughly depended on the van der Waals volume of the side chains.
  
  
  CONCLUSIONS
  The functional importance of proline and uncharged polar residues in the highly conserved region of mouse Slc10a2 was determined. This information will contribute to the design of bile acid-conjugated prodrugs for efficient drug delivery or SLC10A2 inhibitors for hypercholesterolemia treatment.
authors: Laboratory of Molecular Nutrition, Kyoto Prefectural University, Shimogamo, Sakyo-ku, Kyoto, Japan. tsaeki@kpu.ac.jp
authors: Tohru
authors: T
authors: Saeki
authors: Kosuke
authors: K
authors: Sato
authors: Shiho
authors: S
authors: Ito
authors: Keisuke
authors: K
authors: Ikeda
authors: Ryuhei
authors: R
authors: Kanamoto
mesh_terms: D000818:Animals; D001647:Bile Acids and Salts / Q000235:genetics / Q000378:metabolism; D001692:Biological Transport; D017124:Conserved Sequence; D004252:DNA Mutational Analysis / Q000379:methods; D007082:Ileum / Q000166:cytology / Q000378:metabolism*; D007700:Kinetics; D051379:Mice; D009154:Mutation; D029363:Organic Anion Transporters, Sodium-Dependent / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D011392:Proline / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D013329:Structure-Activity Relationship; D027981:Symporters / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D013656:Taurocholic Acid / Q000235:genetics / Q000378:metabolism
chemical_list: D001647:Bile Acids and Salts; D029363:Organic Anion Transporters, Sodium-Dependent; D027981:Symporters; C071908:sodium-bile acid cotransporter; D013656:Taurocholic Acid; D011392:Proline
references: Naunyn Schmiedebergs Arch Pharmacol. 2006 Mar;372(6):413-31
references: 16541252
references: Science. 1999 May 21;284(5418):1362-5
references: 10334992
references: Am J Physiol. 1998 Jan;274(1):G157-69
references: 9458785
references: Biochemistry. 1999 Aug 31;38(35):11379-88
references: 10471288
references: Biochemistry. 2004 Sep 14;43(36):11380-92
references: 15350125
references: Biochemistry. 2002 Jun 11;41(23):7253-66
references: 12044156
references: Biochemistry. 2008 Mar 25;47(12):3606-14
references: 18311924
references: Biochemistry. 2006 Jan 24;45(3):943-53
references: 16411770
references: Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):931-6
references: 11535543
references: J Biol Chem. 1998 Dec 25;273(52):34691-5
references: 9856990
references: J Biol Chem. 2008 Jul 25;283(30):20653-63
references: 18508772
references: J Clin Invest. 1994 Mar;93(3):1326-31
references: 8132774
references: J Biol Chem. 1994 Jan 14;269(2):1340-7
references: 8288599
references: J Lipid Res. 2007 Dec;48(12):2664-72
references: 17720959
references: J Biochem. 1999 Apr;125(4):846-51
references: 10101301
references: Hum Genet. 2009 May;125(4):381-91
references: 19184108
references: EMBO J. 2006 Apr 5;25(7):1419-25
references: 16541101
references: Mol Pharm. 2004 Jan 12;1(1):40-8
references: 15832499
references: Nature. 2006 Jan 26;439(7075):484-9
references: 16400329
references: Cancer Lett. 1999 Oct 18;145(1-2):115-20
references: 10530778
references: J Clin Invest. 1997 Apr 15;99(8):1880-7
references: 9109432
references: Biochemistry. 2005 Jun 21;44(24):8908-17
references: 15952798
references: J Biol Chem. 2003 Feb 7;278(6):4000-9
references: 12435749
references: Pharm Res. 2006 Jul;23(7):1451-9
references: 16783481
references: J Exp Bot. 2002 Sep;53(376):1991-3
references: 12177140
references: Science. 1999 May 21;284(5418):1365-8
references: 10334993
references: Biochemistry. 2005 Oct 25;44(42):13702-12
references: 16229460
references: Biosci Biotechnol Biochem. 2007 Aug;71(8):1865-72
references: 17690477
references: J Pediatr Gastroenterol Nutr. 2001 Apr;32(4):407-17
references: 11396803
references: Eur J Biochem. 2003 Mar;270(6):1117-27
references: 12631271
references: Nature. 2011 Oct 05;478(7369):408-11
references: 21976025
references: J Lipid Res. 2007 Dec;48(12):2693-700
references: 17823457
references: Biosci Biotechnol Biochem. 2009 Jul;73(7):1535-40
references: 19584562
references: Mol Pharmacol. 2006 Nov;70(5):1565-74
references: 16899538